85 related articles for article (PubMed ID: 3103909)
21. Effects of multiple risk factors for hepatocellular carcinoma on formation of aflatoxin B1-DNA adducts.
Yu MW; Lien JP; Liaw YF; Chen CJ
Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):613-9. PubMed ID: 8824363
[TBL] [Abstract][Full Text] [Related]
22. Restricted repair of aflatoxin B1 induced damage in alpha DNA of monkey cells.
Leadon SA; Zolan ME; Hanawalt PC
Nucleic Acids Res; 1983 Aug; 11(16):5675-89. PubMed ID: 6412212
[TBL] [Abstract][Full Text] [Related]
23. Preferential carcinogen-DNA adduct formation at codons 12 and 14 in the human K-ras gene and their possible mechanisms.
Hu W; Feng Z; Tang MS
Biochemistry; 2003 Aug; 42(33):10012-23. PubMed ID: 12924950
[TBL] [Abstract][Full Text] [Related]
24. Mapping the binding site of aflatoxin B1 in DNA: systematic analysis of the reactivity of aflatoxin B1 with guanines in different DNA sequences.
Benasutti M; Ejadi S; Whitlow MD; Loechler EL
Biochemistry; 1988 Jan; 27(1):472-81. PubMed ID: 2831961
[TBL] [Abstract][Full Text] [Related]
25. Aflatoxin B1-induced DNA damage in Labeo rohita: protective effect of an antioxidant supplement, Amrita Bindu.
Madhusudhanan N; Kavithalakshmi SN; Shanmugasundaram ER; Shanmugasundaram KR
Basic Clin Pharmacol Toxicol; 2006 May; 98(5):473-9. PubMed ID: 16635106
[TBL] [Abstract][Full Text] [Related]
26. The use of monoclonal antibody affinity columns for assessing DNA damage and repair following exposure to aflatoxin B1.
Groopman JD; Kensler TW
Pharmacol Ther; 1987; 34(2):321-34. PubMed ID: 3120202
[TBL] [Abstract][Full Text] [Related]
27. Quantitation of aflatoxin B1-modified DNA using monoclonal antibodies.
Groopman JD; Haugen A; Goodrich GR; Wogan GN; Harris CC
Cancer Res; 1982 Aug; 42(8):3120-4. PubMed ID: 6807538
[TBL] [Abstract][Full Text] [Related]
28. A comparison of the effects of aflatoxin B1 on the livers of rats and duck hepatitis B virus-infected and noninfected ducks.
Seawright AA; Snowden RT; Olubuyide IO; Riley J; Judah DJ; Neal GE
Hepatology; 1993 Jul; 18(1):188-97. PubMed ID: 8325610
[TBL] [Abstract][Full Text] [Related]
29. 1,3-butadiene: cancer, mutations, and adducts. Part IV: Molecular dosimetry of 1,3-butadiene.
Blair IA; Oe T; Kambouris S; Chaudhary AK
Res Rep Health Eff Inst; 2000 Mar; (92):151-90; discussion 211-9. PubMed ID: 10925841
[TBL] [Abstract][Full Text] [Related]
30. Aflatoxin B1-induced DNA damage and its repair.
Bedard LL; Massey TE
Cancer Lett; 2006 Sep; 241(2):174-83. PubMed ID: 16458422
[TBL] [Abstract][Full Text] [Related]
31. Enhanced sensitivity to anti-benzo(a)pyrene-diol-epoxide DNA damage correlates with decreased global genomic repair attributable to abrogated p53 function in human cells.
Wani MA; Zhu Q; El-Mahdy M; Venkatachalam S; Wani AA
Cancer Res; 2000 Apr; 60(8):2273-80. PubMed ID: 10786695
[TBL] [Abstract][Full Text] [Related]
32. Aflatoxin B1 formamidopyrimidine adducts are preferentially repaired by the nucleotide excision repair pathway in vivo.
Alekseyev YO; Hamm ML; Essigmann JM
Carcinogenesis; 2004 Jun; 25(6):1045-51. PubMed ID: 14742311
[TBL] [Abstract][Full Text] [Related]
33. Formation and repair of cisplatin-induced adducts to DNA in cultured normal and repair-deficient human fibroblasts.
Dijt FJ; Fichtinger-Schepman AM; Berends F; Reedijk J
Cancer Res; 1988 Nov; 48(21):6058-62. PubMed ID: 3167856
[TBL] [Abstract][Full Text] [Related]
34. Aflatoxin-albumin adducts: a basis for comparative carcinogenesis between animals and humans.
Wild CP; Hasegawa R; Barraud L; Chutimataewin S; Chapot B; Ito N; Montesano R
Cancer Epidemiol Biomarkers Prev; 1996 Mar; 5(3):179-89. PubMed ID: 8833618
[TBL] [Abstract][Full Text] [Related]
35. NMR-studies of carcinogen reactions with DNA: ethylene dibromide and aflatoxin B1.
Harris TM
J Pharm Biomed Anal; 1990; 8(2):195-204. PubMed ID: 2128814
[TBL] [Abstract][Full Text] [Related]
36. Sensitivity and single-strand DNA break repair in Chinese hamster mutants exposed to the carcinogen aflatoxin B1 epoxide and its dichloride model.
Martin EA; Waters R
Mutat Res; 1992 May; 273(3):243-51. PubMed ID: 1374845
[TBL] [Abstract][Full Text] [Related]
37. Specificity of aflatoxin B1 binding on human proto-oncogene nucleotide sequence.
Modali R; Yang SS
Prog Clin Biol Res; 1986; 207():147-58. PubMed ID: 3083425
[No Abstract] [Full Text] [Related]
38. Molecular dosimetry of hepatic aflatoxin B1-DNA adducts: linear correlation with hepatic cancer risk.
Bechtel DH
Regul Toxicol Pharmacol; 1989 Aug; 10(1):74-81. PubMed ID: 2505337
[TBL] [Abstract][Full Text] [Related]
39. Combined in vivo DNA binding and tumor dose-response studies to investigate the molecular dosimetry concept.
Dashwood RH; Loveland PM; Fong AT; Hendricks JD; Bailey GS
Prog Clin Biol Res; 1990; 340D():335-44. PubMed ID: 2115176
[No Abstract] [Full Text] [Related]
40. DNA strand scission and apurinic sites induced by photoactivated aflatoxins.
Stark AA; Malca-Mor L; Herman Y; Liberman DF
Cancer Res; 1988 Jun; 48(11):3070-6. PubMed ID: 3130184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
